Table 2.
WKY |
SHR
|
|||||
---|---|---|---|---|---|---|
Basal | NS | Increase | Basal | NS | Increase | |
4–6 wk old | 0.02±0.03 | 1.09±0.15 | 1.07 | 0.03±0.01 | 1.14±0.15 | 1.11 |
10–12 wk old | 0.03±0.004 | 0.85±0.09 | 0.82 | 0.06±0.02 | 1.19±0.09* | 1.13 |
18–20 wk old | 0.07±0.02 | 1.22±0.18 | 1.15 | 0.08±0.02 | 1.76±0.09*† | 1.68 |
Results are expressed as means ± SE of neuropeptide Y overflow (in ng/ml); n = 5–7 preparations.
P < 0.05 compared with WKY rats;
P < 0.05 compared with SHRs of 4–6 and 10–12 wk of age.